financetom
Business
financetom
/
Business
/
Research Alert: K: Challenging Q2 Results; Mars Merger Now To Close By End Of 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: K: Challenging Q2 Results; Mars Merger Now To Close By End Of 2025
Jul 31, 2025 7:14 AM

09:45 AM EDT, 07/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

K posted challenging Q2 2025 results with organic sales growing just 0.3% as volumes declined 3.8% in North America, 6.2% in Europe, and 4.6% in Latin America, though AMEA volumes surged 20.3%, led by strong noodles business growth in Africa. Adj-EPS of $0.94 fell 7% Y/Y while adj-operating profit declined 5% to $477M, with results not comparable to consensus given the pending merger circumstances. The pending merger with Mars remains on track despite facing regulatory approval delays. K now expects the Mars transaction to close by the end of 2025, pushed back from the previous 1H 2025 timeline due to longer-than-expected regulatory approvals, especially in the European Union, where scrutiny has intensified. The company will focus on improving underlying demand trends as it prepares for its new chapter with Mars, though near-term challenges persist across key markets amid continued widespread category softness affecting salty snack companies industry-wide.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apple nears $4 trillion valuation as shares surge on strong iPhone 17 demand
Apple nears $4 trillion valuation as shares surge on strong iPhone 17 demand
Oct 20, 2025
(Reuters) -Apple ( AAPL ) shares surged to an all-time high on Monday, with the iPhone maker close to becoming the third company to hit a $4 trillion market valuation as data showed strong momentum for the latest iPhone. Data from research firm Counterpoint showed the iPhone 17 series outperformed its predecessor in early sales in China and the United...
Kenvue urges US FDA to deny request for Tylenol's autism warning
Kenvue urges US FDA to deny request for Tylenol's autism warning
Oct 20, 2025
Oct 20 (Reuters) - Kenvue ( KVUE ) has urged U.S. regulators to reject a request for a warning of autism on its popular over-the-counter pain medication Tylenol for use during pregnancy, according to a petition. ...
Update: Cleveland-Cliffs Shares Rise After Q3 Revenue Increases
Update: Cleveland-Cliffs Shares Rise After Q3 Revenue Increases
Oct 20, 2025
12:33 PM EDT, 10/20/2025 (MT Newswires) -- (Updates with recent stock price movement in the headline and first paragraph.) Cleveland-Cliffs ( CLF ) shares were up almost 21% in recent Monday trading after the company reported a Q3 adjusted loss that widened year-over-year and higher revenue compared with a year earlier. The company reported a Q3 adjusted net loss of...
US CBO says orphan drug exmption could add $6 billion more to cost of 'Big Beautiful Bill'
US CBO says orphan drug exmption could add $6 billion more to cost of 'Big Beautiful Bill'
Oct 20, 2025
Oct 20 (Reuters) - The U.S. Congressional Budget Office said on Monday that new exemptions to drug price negotiations for several blockbuster cancer medicines under President Trump's One Big Beautiful Bill Act will cost the government up to $6 billion more over the next decade. The new estimate reflects updated information about the eligibility of Johnson & Johnson's ( JNJ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved